Optimizing Outcomes in Iron Deficiency Anemia: Adaptive Approaches for the OB/GYN
Iron deficiency anemia is a far-reaching condition of immense clinical impact in women’s health, with implications ranging from the global, epidemiological scale, to individual OB/GYN practices, and most importantly, to individual patients. As such, this educational initiative is designed to address the myriad challenges of iron deficiency anemia (IDA) in women’s health using a dynamic, multifaceted approach targeted to OB/GYNs. Given their role as frontline clinicians with expertise across a multiplicity of women’s health conditions, OB/GYNs are optimally positioned within the healthcare team to ensure the provision of safe, effective, and evidence-based treatment approaches for female patients with IDA. This initiative will provide a review of the epidemiology of IDA, including obstetrical morbidity and mortality implications, as well as equip OB/GYNs with the tools they need to identify patients at high risk for IDA within their practice and properly prevent, diagnose, and treat IDA in those patients. Abnormal uterine bleeding (AUB) will be emphasized as a preeminent cause of IDA in women, and attendees will be given strategies they can employ to overcome the harmful cultural stigmas surrounding AUB. And lastly, using a case-based approach, this activity will evaluate currently-available IV and oral iron supplementation modalities, with a focus on tailored treatment strategies for patients refractory to oral iron therapy.
Obstetricians, gynecologists, and women’s health professionals.
- Review the epidemiology of iron deficiency anemia, examining its impact on obstetrical morbidity and mortality, and on patient quality of life.
- Identify patients in the OB/GYN practice setting who are at an elevated risk for developing IDA.
- Discuss clinically-appropriate iron studies for the diagnosis and assessment of IDA, including when to order and how to interpret results.
- Recognize AUB as a prominent IDA etiology, and describe how the cultural normalization of heavy menstrual bleeding (HMB) leads to under-diagnosis of IDA.
- Using a case-based format, evaluate available iron supplementation approaches, including IV and oral modalities, and formulate individualized treatment plans for the IDA patient refractory to oral therapy.
Welcome and Introductions/Pre-test
Iron Deficiency Anemia in Women’s Health: Epidemiology and Clinical Gravity
Iron Deficiency Anemia in the Clinic: Abnormal Uterine Bleeding (AUB) and Other Risk Factors
Iron Deficiency Anemia in Your Patient: Examining IV and Oral Iron Supplementation Strategies
Conversations with the Expert: Audience Q&A/Post-test
Lee Shulman, MD, FACMG, FACOG
Northwestern University Feinberg School of Medicine
Lee P. Shulman, MD is the Anna Ross Lapham Professor in Obstetrics and Gynecology in the Division of Clinical Genetics at the Feinberg School of Medicine at Northwestern University in Chicago, Illinois. He also serves as the Medical Director for Insight Medical Genetics and Reproductive Genetics Innovations. Dr. Shulman is an Adjunct Professor in the Department of Medicinal Chemistry and Pharmacognosy at the University of Illinois at Chicago College of Pharmacy. A Fellow of the American College of Obstetricians and Gynecologists and a Founding Fellow of the American College of Medical Genetics, Dr. Shulman is a member of numerous regional, national and international organizations that pertain to the health and care of women. His work has been recognized regionally and nationally; most recently, he was again included in the list of “Top Doctors” in Chicago (2007-19) and the United States (2005-19). Dr. Shulman served as Chair of the Board of Trustees of the Association of Reproductive Health Professionals from 2006-2008, is a Past President of the Central Association of Obstetricians and Gynecologists and the current Chair of the Fetoscopy Working Group. A frequent contributor to the peer-reviewed and informational literature with over 200 peer-reviewed articles and 60 book chapters, Dr. Shulman’s major research interests are in contraception, reproductive and cancer genetics, menopause, women’s healthcare advocacy and botanical interventions in women’s health.
Planner and Faculty Disclosures:
In accordance with the Food and Drug Administration, the speakers have disclosed that there is the potential for discussions concerning off-label uses of a commercial product/device during this educational activity.
Any person who may contribute to the content of this continuing education activity must disclose relevant relationships (and any known relationships of their spouse/partner) with commercial interests whose products or services are discussed in educational presentations. A commercial interest is defined as any entity producing, marketing, re-selling, or distributing health care goods or services consumed by, or used on, patients. Relevant relationships include receiving from a commercial interest research grants, consultant fees, travel, other benefits, or having a self-managed equity interest in a company.
Disclosure of a relationship is not intended to suggest or condone any bias in any presentation but is made to provide participants with information that might be of potential importance to their evaluation of a presentation.
Bryan Taylor, PharmD–has no relevant financial relationships to disclose in relation to the content of this activity.
Lee P. Shulman MD FACMG FACOG–has disclosed that he is a consultant for Bayer, Biogix, Celula China, Leon Pharmaceuticals, Natera, and Vermillion. He received financial support from Astellas and is on the speakers' bureau for Lupin Pharmaceuticals.
Jessica Kiley, MD, MPH–has disclosed that she is a consultant for CVS Caremark.
In support of improving patient care, Creative Educational Concepts is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
CEC designates this live educational activity for a maximum of 1.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Upon completion of a CE request form, statements of credit for physicians will be issued within 30 business days.
- 1.00 AMA PRA Category 1 Credit™In support of improving patient care, Creative Educational Concepts is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
CEC designates this live educational activity for a maximum of 1.00 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
- 1.00 Participation